↓ Skip to main content

Interferon beta for secondary progressive multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs
2 blogs
twitter
2 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interferon beta for secondary progressive multiple sclerosis
Published in
Cochrane database of systematic reviews, January 2012
DOI 10.1002/14651858.cd005181.pub3
Pubmed ID
Authors

Loredana La Mantia, Laura Vacchi, Carlo Di Pietrantonj, George Ebers, Marco Rovaris, Sten Fredrikson, Graziella Filippini

Abstract

Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase of the disease.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 3%
France 1 3%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 21%
Student > Postgraduate 5 17%
Student > Ph. D. Student 5 17%
Other 4 14%
Professor 3 10%
Other 6 21%
Readers by discipline Count As %
Medicine and Dentistry 14 48%
Unspecified 4 14%
Neuroscience 4 14%
Agricultural and Biological Sciences 3 10%
Sports and Recreations 1 3%
Other 3 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2019.
All research outputs
#952,389
of 13,481,034 outputs
Outputs from Cochrane database of systematic reviews
#2,947
of 10,617 outputs
Outputs of similar age
#12,243
of 210,189 outputs
Outputs of similar age from Cochrane database of systematic reviews
#147
of 532 outputs
Altmetric has tracked 13,481,034 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,617 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,189 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 532 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.